Tag: chronic rhinosinusitis with nasal polyps market forecast

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the chronic rhinosinusitis with nasal polyps market?

The chronic rhinosinusitis with nasal polyps market has grown considerably in recent years. It will increase from $4.02 billion in 2024 to $4.4 billion in 2025, at a compound annual growth rate (CAGR) of 9.3%. This growth is driven by a rise in prevalence, advances in diagnosis, innovations in treatment, greater patient awareness, and higher healthcare spending.

What will be the chronic rhinosinusitis with nasal polyps market size in the future?

The chronic rhinosinusitis with nasal polyps market is expected to reach $6.21 billion by 2029 at a 9.0% CAGR. Growth drivers include increased biologic therapies, personalized medicine, technological advancements, regulatory approvals, and patient-centric care. Key trends include innovative drug delivery systems, understanding of pathophysiology, clinical trials, and increased awareness.

Get your chronic rhinosinusitis with nasal polyps market report here!

https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report

What main drivers are fueling expansion in the chronic rhinosinusitis with nasal polyps market?

The increasing prevalence of respiratory diseases is expected to drive the growth of the chronic rhinosinusitis with nasal polyps market. Factors like air pollution, smoking, and climate change are increasing the incidence of respiratory conditions, including chronic rhinosinusitis with nasal polyps. As the prevalence of asthma and COPD rises, so does the need for treatments for related conditions like CRSwNP. According to the National Center for Health Statistics, the prevalence of asthma among U.S. adults increased from 8.4% to 8.7% between 2021 and 2022, signaling greater demand for diagnostic and treatment options for respiratory diseases. This increase in respiratory diseases is driving the chronic rhinosinusitis with nasal polyps market.

What key areas define the segmentation of the global chronic rhinosinusitis with nasal polyps market?

The chronic rhinosinusitis with nasal polyps market covered in this report is segmented –

1) By Treatment: Medications, Surgical Methods

2) By Route Of Administration: Nasal, Oral, Other Routes Of Administration

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids), Biologics (Monoclonal Antibodies Like Dupilumab), Antibiotics, Antihistamines, Leukotriene Modifiers

2) By Surgical Methods: Endoscopic Sinus Surgery (ESS), Polypectomy (Polyps Removal), Balloon Sinuplasty

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17113&type=smp

Who are the dominant players expanding their reach in the chronic rhinosinusitis with nasal polyps market?

Major companies operating in the chronic rhinosinusitis with nasal polyps market are Pfizer Inc., Roche Holding AG, Merck & Co Inc, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Boehringer Ingelheim International GmbH, Amgen Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Daiichi Sankyo Company Limited, Olympus Corporation, Eisai Co Ltd, Smith & Nephew PLC, Genentech USA Inc, Mallinckrodt Pharmaceuticals, Lyra Therapeutics Inc, Sunovion Pharmaceuticals, Acclarent Inc., Optinose US Inc, SinuSys Corporation, Biohaven Pharmaceuticals

How are evolving market trends shaping chronic rhinosinusitis with nasal polyps Strategies?

Companies in the chronic rhinosinusitis with nasal polyps market are focusing on alternative therapies, like anti-IL-5 biologics, to improve patient outcomes. Anti-IL-5 biologics target eosinophilic inflammation to treat severe asthma and eosinophilic disorders. For example, in March 2024, US-based Optinose received FDA approval for XHANCE, a nasal spray designed for chronic rhinosinusitis with nasal polyps (CRSwNP). It uses a unique Exhalation Delivery System to improve medication delivery deep into the nasal passages, targeting areas where polyps form and sinuses drain.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17113

Which regions are emerging as leaders in the chronic rhinosinusitis with nasal polyps market?

North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2023. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Chronic Myeloid Leukemia Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-treatment-global-market-report

Drug Delivery Devices Market Opportunities And Strategies To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

Nasal Polyps Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nasal-polyps-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Chronic Rhinosinusitis With Nasal Polyps Market Achieve During 2025–2034, and What Does It Indicate?

The market size for chronic rhinosinusitis with nasal polyps has experienced healthy growth in the past few years. Its size is estimated to escalate from $4.02 billion in 2024 to $4.4 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 9.3%. Factors contributing to the growth observed during the historical period include a rise in prevalence, advancements in diagnostic procedures, innovative treatments, improved patient awareness, and an upswing in healthcare expenditure.

The market for chronic rhinosinusitis with nasal polyps is predicted to experience robust growth in the coming years, reaching $6.21 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. The growth during this forecast period is due to factors such as the development of biologic therapies, the rise of personalized medicine, technological progress, more regulatory approvals, a focus on patient-centric care, and the tracking of epidemiological trends. The forecast period will also see dominant trends such as innovative drug delivery systems, better understanding of pathophysiology, clinical trials, longitudinal studies, heightened awareness, integrated care models, and an increase in prevalence and incidence.

Which Primary Drivers Are Supporting the Continued Expansion of the Chronic Rhinosinusitis With Nasal Polyps Market?

As instances of respiratory ailments continue to rise, it’s predicted that this will fuel the expansion of the chronic rhinosinusitis with nasal polyps market. A myriad of factors, from air pollution and smoking, to climate change, allergies, occupational risks, and infections, contributes to the growing prevalence of respiratory disorders. These conditions, including asthma and chronic obstructive pulmonary disease (COPD), are increasingly prevalent, thus heightening the incidence of related conditions such as CRSwNP. As a result, there’s an increased demand for diagnosis methods, treatment options, and surgical procedures. For example, data released by the National Center for Health Statistics (NCHS) in the U.S indicated in May 2024 that the prevalence of current asthma among American adults aged 18 and older saw a surge from 8.4% in 2021 to 8.7% in 2022. Similarly, the incidence of asthma attacks in this adult demographic grew from 3.3% in 2021 to 3.7% in 2022. Consequently, the rising occurrence of respiratory infections is bound to bolster the growth of the chronic rhinosinusitis with nasal polyps market.

Request Your Free Chronic Rhinosinusitis With Nasal Polyps Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=17113&type=smp

Who Are the Key Firms Paving the Way for Growth in the Chronic Rhinosinusitis With Nasal Polyps Market?

Major companies operating in the chronic rhinosinusitis with nasal polyps market are:

• Pfizer Inc.

• Roche Holding AG

• Merck & Co Inc

• Bayer AG

• Sanofi SA

What Are the Most Influential Trends Currently Shaping the Chronic Rhinosinusitis With Nasal Polyps Market?

Leading companies in the chronic rhinosinusitis with nasal polyps market are exploring alternative treatment methods like anti-IL-5 biologics to boost patient results and secure a competitive edge. This targeted therapy helps decrease eosinophilic inflammation in severe asthma and eosinophilic disorders, thereby enhancing patients’ symptom management and overall quality of life. A case in point, Optinose, an American pharmaceutical firm specializing in developing and marketizing breakthrough products, acquired U.S. Food and Drug Administration (FDA) approval for the usage of XHANCE, its prescription nasal spray crafted exclusively for the treatment of adult chronic rhinosinusitis (CRS), in particular for both chronic rhinosinusitis with nasal polyps (CRSwNP) and without polyps (CRSsNP). The active ingredient is fluticasone propionate, a corticosteroid identified for its anti-inflammatory effects in the nasal cavity. The product also comes with the distinctive Exhalation Delivery System (EDS) which enables patients to exhale into the device as they administer the spray, enhancing the distribution of medication deep within the nasal passageways, effectively targeting regions where nasal polyps originate and sinuses discharge.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report

What Are the Primary Segments of the Chronic Rhinosinusitis With Nasal Polyps Market and Their Roles in Growth Dynamics?

The chronic rhinosinusitis with nasal polyps market covered in this report is segmented –

1) By Treatment: Medications, Surgical Methods

2) By Route Of Administration: Nasal, Oral, Other Routes Of Administration

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids), Biologics (Monoclonal Antibodies Like Dupilumab), Antibiotics, Antihistamines, Leukotriene Modifiers

2) By Surgical Methods: Endoscopic Sinus Surgery (ESS), Polypectomy (Polyps Removal), Balloon Sinuplasty

Which Regions Are Essential for the Growth of the Chronic Rhinosinusitis With Nasal Polyps Market?

North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2023. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Chronic Rhinosinusitis With Nasal Polyps Market Defined?

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a persistent inflammatory condition of the sinuses and nasal passages characterized by the presence of nasal polyps. Nasal polyps are non-cancerous, swollen masses of tissue that grow in the nasal passages or sinuses due to chronic inflammation. It is detected through a combination of symptom review, clinical examination, imaging studies, allergy testing, and sometimes biopsy.

Browse Through More Similar Reports By The Business Research Company:

Chronic Myeloid Leukemia Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-treatment-global-market-report

Drug Delivery Devices Market Opportunities And Strategies To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

Nasal Polyps Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nasal-polyps-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Expansion Rate of the Chronic Rhinosinusitis With Nasal Polyps Market in the 2024-2033 Forecast?

The chronic rhinosinusitis with nasal polyps market size has seen robust growth in recent years. It is expected to increase from $3.69 billion in 2023 to $4.02 billion in 2024, reflecting a CAGR of 9%. Contributing factors to this growth include a rising prevalence, advancements in diagnosis, innovations in treatment, heightened patient awareness, and increasing healthcare expenditure.

The chronic rhinosinusitis with nasal polyps market size is expected to experience strong growth, projected to reach $5.7 billion by 2028 with a CAGR of 9.1%. This growth can be attributed to the rise in biologic therapies, increasing personalized medicine, technological advancements, growing regulatory approvals, a focus on patient-centric care, and monitoring epidemiological trends. Major trends include innovative drug delivery systems, deeper understanding of pathophysiology, clinical trials, longitudinal studies, heightened awareness, integrated care models, and prevalence studies.

What Factors Are Catalyzing the Growth of the Chronic Rhinosinusitis With Nasal Polyps Market?

The rising incidence of respiratory diseases is likely to propel the growth of the chronic rhinosinusitis with nasal polyps market in the future. Respiratory diseases encompass various conditions affecting the respiratory system, including the lungs and airways. The increase in respiratory diseases is driven by a complex mix of factors such as air pollution, smoking, climate change, infections, occupational hazards, and allergies. As more individuals experience conditions like asthma and chronic obstructive pulmonary disease (COPD), the occurrence of related conditions like CRSwNP also increases, leading to higher demand for diagnostic tools, treatments, and surgical procedures. For example, in May 2024, the National Center for Health Statistics (NCHS) reported that the prevalence of current asthma among U.S. adults aged 18 and over rose from 8.4% in 2021 to 8.7% in 2022. Furthermore, asthma episodes in this demographic grew from 3.3% in 2021 to 3.7% in 2022. Thus, the increasing prevalence of respiratory diseases will drive the growth of the chronic rhinosinusitis with nasal polyps market.

Claim Your Free Sample of the Global Chronic Rhinosinusitis With Nasal Polyps Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=17113&type=smp

Which Segments Are Important in the Chronic Rhinosinusitis With Nasal Polyps Market Landscape?

The chronic rhinosinusitis with nasal polyps market covered in this report is segmented –

1) By Treatment: Medications, Surgical Methods
2) By Route Of Administration: Nasal, Oral, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Are the Groundbreaking Trends in the Chronic Rhinosinusitis With Nasal Polyps Market?

Major companies in the chronic rhinosinusitis with nasal polyps market are focusing on alternative therapies, such as anti-IL-5 biologics, to improve patient outcomes. Anti-IL-5 biologics provide targeted therapy to reduce eosinophilic inflammation in conditions like severe asthma. For instance, in July 2021, GlaxoSmithKline (GSK), a UK-based pharmaceutical company, received FDA approval for Nucala (mepolizumab), a monoclonal antibody for treating chronic rhinosinusitis with nasal polyps.

Order Now for Fast Delivery of Your Chronic Rhinosinusitis With Nasal Polyps Market Report!

https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report

What Are the Key Regions Powering Growth in the Chronic Rhinosinusitis With Nasal Polyps Market?

North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2023. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the chronic rhinosinusitis with nasal polyps market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Chronic Rhinosinusitis With Nasal Polyps Market Include

1. Chronic Rhinosinusitis With Nasal Polyps Market Executive Summary
2. Chronic Rhinosinusitis With Nasal Polyps Market Segments
3. Chronic Rhinosinusitis With Nasal Polyps Market Size And Template Market Growth Rate
4.  Key Chronic Rhinosinusitis With Nasal Polyps Market Trends
5. Major Chronic Rhinosinusitis With Nasal Polyps Market Drivers
……
25. Key Mergers And Acquisitions In The Chronic Rhinosinusitis With Nasal Polyps Market
26. Top Chronic Rhinosinusitis With Nasal Polyps Companies
27. Chronic Rhinosinusitis With Nasal Polyps Market Opportunities And Strategies
28. Chronic Rhinosinusitis With Nasal Polyps Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:

Late Stage Chronic Kidney Disease Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

Printed Circuit Board Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/printed-circuit-board-global-market-report

Chronic Venous Occlusions Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chronic-venous-occlusions-treatment-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2024, the chronic rhinosinusitis with nasal polyps market is expected to show significant growth in the forecast period.

The market for chronic rhinosinusitis with nasal polyps (CRSwNP) has seen significant growth in recent years, reflecting advancements in medical treatment and a rising prevalence of respiratory diseases. This blog will explore the market’s recent and projected growth, key drivers, trends, and significant players shaping the industry.

Current Market Size and Growth Forecast

• Market Expansion: The CRSwNP market grew from $3.69 billion in 2023 to $4.02 billion in 2024, representing a compound annual growth rate (CAGR) of 9%.
• Future Growth: By 2028, the market is expected to reach $5.7 billion, maintaining a robust CAGR of 9.1%.
• Contributing Factors: Growth in this sector is fueled by increasing patient awareness, advancements in treatment innovations, and rising healthcare spending.

Market Drivers: The Impact of Respiratory Diseases

• Increasing Prevalence: Respiratory diseases like asthma and COPD are on the rise, driving demand for CRSwNP treatments.
• Contributing Factors: Air pollution, smoking, climate change, and allergies are significant contributors to the rising incidence of respiratory diseases.
• Impact on Market: The growing prevalence of these conditions has led to a greater need for diagnostic tools, treatments, and surgical interventions for CRSwNP.

View More On The Chronic Rhinosinusitis With Nasal Polyps Market Report 2024 – https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report

Key Market Players

• Major Companies: The market includes global pharmaceutical and medical technology giants such as Pfizer Inc., Roche Holding AG, Merck & Co Inc., Bayer AG, and Sanofi SA.
• Market Influence: These companies play a pivotal role in driving innovation, expanding product portfolios, and influencing market dynamics through strategic mergers and acquisitions.

Trends Shaping the Market: Advancements in Biologics

• Focus on Anti-IL-5 Biologics: Companies are increasingly focusing on alternative therapies like anti-IL-5 biologics, which offer targeted treatment for patients with CRSwNP.
• Notable Development: In July 2021, GlaxoSmithKline (GSK) received FDA approval for Nucala (mepolizumab) for treating CRSwNP, highlighting the shift towards biologic therapies in managing chronic sinus conditions.

Strategic Mergers and Acquisitions

• Medtronic’s Strategic Move: In May 2022, Medtronic Plc acquired Intersect ENT Inc., adding the company’s PROPEL and SINUVA sinus implant product lines to its ENT portfolio.
• Impact on Market: This acquisition not only expanded Medtronic’s product offerings but also enhanced its ability to provide comprehensive treatment options for CRSwNP, strengthening its market position.

Market Segmentation

• Treatment Types: The market is segmented by treatments, including medications and surgical methods.
• Routes of Administration: These include nasal, oral, and other routes, catering to varying patient needs and preferences.
• Distribution Channels: CRSwNP treatments are available through hospital pharmacies, retail pharmacies, and online pharmacies, offering multiple access points for patients.

Regional Insights

• North America Leading the Market: In 2023, North America emerged as the largest region in the CRSwNP market, driven by advanced healthcare infrastructure, high patient awareness, and significant investment in medical research.

The chronic rhinosinusitis with nasal polyps market is on a steady growth trajectory, driven by increasing disease prevalence, innovation in treatment options, and strategic industry moves. As the market continues to evolve, it presents significant opportunities for companies to enhance patient care through innovative therapies and strategic expansion.

Request A Sample Of The Global Chronic Rhinosinusitis With Nasal Polyps Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=17113&type=smp